Sweat Gland Function in Patients With Failed Back Surgery Syndrome, Treated With Spinal Cord Stimulation
1 other identifier
interventional
23
1 country
1
Brief Summary
This study is investigating sweat gland function during on and off states of the spinal cord stimulator, in patients with failed back surgery syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2020
CompletedStudy Start
First participant enrolled
December 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2020
CompletedFirst Posted
Study publicly available on registry
December 16, 2020
CompletedJanuary 29, 2021
January 1, 2021
Same day
December 2, 2020
January 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Sweat gland function by measuring Electrochemical Skin Conductances (ESC)
The investigators will examine the difference in sweat gland function between both measurements (SCS on versus SCS off), measured with the Sudoscan.
The change between the measurement while SCS is switched off and while SCS is switched on. Total study duration lasts one day.
Secondary Outcomes (1)
Pain intensity scores using the Visual Analogue Scale
Two times on the same day; once while SCS is switched off and once while SCS is switched on. Total study duration lasts one day.
Study Arms (2)
SCS off
EXPERIMENTALSCS is switched off
SCS on
EXPERIMENTALSCS is switched on
Interventions
Eligibility Criteria
You may qualify if:
- Subject is at least 18 years old.
- Diagnosis of FBSS (Failed conservative treatments for pain including but not limited to pharmacological therapy and physical therapy) and currently being treated with spinal cord stimulation.
- Cognitive and language functioning enabling coherent communication between the examiner and the participant.
You may not qualify if:
- Patients with major psychiatric problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitair Ziekenhuis Brussel
Jette, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maarten Moens, Prof. dr.
Universitair Ziekenhuis Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
December 2, 2020
First Posted
December 16, 2020
Study Start
December 12, 2020
Primary Completion
December 12, 2020
Study Completion
December 12, 2020
Last Updated
January 29, 2021
Record last verified: 2021-01